ArticleInternational journal of molecular sciences2022

Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice.

Jia-Shiong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.